Anti-CD22 x Anti-saporin Bispecific Antibody (IgG-IgG) (BSIG-053)

Anti-CD22 x Anti-saporin Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD22 and anti-saporin parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can be used in pretargeting system and deliver immunotoxin to tumor cells. It is designed for the research of Lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

CD22 & saporin

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Pretargeting system for immunotoxin delivery

Related Disease

Lymphoma

Targets

Target 1

CD22

Gene ID

933

UniProt ID

P20273

Alternative Names

CD22; CD22 molecule; Cluster of differentiation 22; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2

Target 2

saporin

Alternative Names

Saporin; Ribosome inactivating protein; RIP

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CD22 x Anti-saporin Bispecific Antibody (IgG-IgG) (BSIG-053). Click the button below to contact us or submit your feedback about this product.

Anti-CD22 x Anti-saporin Bispecific Antibody (IgG-IgG) (CAT#: BSIG-053)

Specifications

Targets

Customer Reviews and Q&As